Rising Prevalence of Overactive Bladder Syndrome Drives Market Growth

-

The global overactive bladder treatment market is expected to witness significant growth in the coming years. According to the latest market research report, the market is projected to reach USD 4.2 billion by 2027, growing at a CAGR of 3.6% during the forecast period from 2022 to 2027. This growth can be attributed to several factors such as the rising prevalence of overactive bladder syndrome across the world and the launch of novel drugs with lesser side-effects.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219938791

In addition, the adoption of technologically advanced treatment options for OAB treatment is also expected to support market growth in the coming years. This has led to increased competition among the market players, with several companies adopting various strategies to sustain market competition.

Astellas Pharma, Teva Pharmaceutical Industries, Pfizer, Medtronic, AbbVie, Viatris, Hisamitsu Pharmaceutical, Johnson Johnson Services, Endo Pharmaceuticals, and others are some of the prominent players operating in the global overactive bladder treatment market.

Astellas Pharma, a Japanese multinational pharmaceutical company, is one of the leading players operating in the overactive bladder treatment market globally. The company provides two major drugs, Betanis/Myrbetriq/BETMIGA and VESIcare. Myrbetriq is one of the most prescribed medications for overactive bladder disorders.

Pfizer, a leading global pharmaceutical company, develops medicines for a wide range of therapeutic areas, including overactive bladder treatment. The company markets its product, TOVIAZ, under the Internal Medicine segment of the Biopharma business.

AbbVie, a diversified research-based biopharmaceutical company, has a comprehensive product portfolio that has leadership positions across various therapeutic areas. The company provides Enablex, extended-release tablets for overactive bladder treatment.

Request Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=219938791

In conclusion, the global overactive bladder treatment market is projected to witness significant growth in the coming years, with several market players adopting strategies to sustain market competition. The launch of novel drugs with lesser side-effects and the adoption of technologically advanced treatment options for OAB treatment are also expected to support market growth in the coming years.

Related Links

https://www.marketsandmarkets.com/Market-Reports/overactive-bladder-treatment-market-219938791.html

https://www.marketsandmarkets.com/PressReleases/overactive-bladder-treatment.asp

https://www.marketsandmarkets.com/ResearchInsight/overactive-bladder-treatment-market.asp

Comments

Post a Comment

Popular posts from this blog

Minimally Invasive Surgical Instruments Market Report, 2026

-
The global minimally invasive surgical instruments market is projected to reach USD 28.9 billion by 2026 from USD 20.2 billion in 2021, at a CAGR of 7.4% during the forecast period. Growth in this market is mainly driven by factors such as the increasing number of surgical procedures worldwide, the advantages of MIS over open surgical techniques, and the increasing adoption of advanced robotics in ASCs. However, the high degree of market consolidation among market players and the requirement of high capital investments are the major factors hampering the growth of this market. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 The key players in this market are Medtronic plc (Ireland), Johnson Johnson (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), Boston Scientific Corporation (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Smith Nephew plc (UK), Zimmer Biomet Holdings, Inc. (US), Becton, Dickinson and Comp...
Read more

Advancements Fueling Cardiac Monitoring Devices Market Growth

-
The global Cardiac Monitoring and Management Devices Market has been experiencing an upward surge, projected to reach an impressive USD 26.8 billion by 2025 from its valuation of USD 22.1 billion in 2020, with a steady Compound Annual Growth Rate (CAGR) of 4.0% from 2020 to 2025. This exponential growth can be attributed to several key factors that continue to shape and propel this industry forward. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55 Factors Driving Cardiac Monitoring Devices Market Growth Rising Cardiovascular Disease Prevalence: The prevalence of cardiovascular diseases (CVD) is on the rise globally, driving the demand for advanced cardiac monitoring devices. This trend is a significant catalyst for the market's growth trajectory. Innovative Product Launches: Market players have been proactive in introducing innovative products, leveraging advanced technologies. These advancements include improved algorithms, simplified...
Read more

Antimicrobial Susceptibility Testing Market : Emerging Market Trends, Top Growing Segments and Future Trends

-
Growth in this  antimicrobial susceptibility testing market is primarily driven by the rising incidence of infectious diseases; technological advancements towards the development of rapid AST technologies; increased funding, research grants, and public-private investments; growing government initiatives to detect and control antimicrobial-resistant species; and the emergence of multidrug resistance due to drug abuse. However, the high cost of automated antimicrobial susceptibility testing systems is expected to limit market growth in the coming years. Complex regulatory frameworks that delay the approval of new microbial susceptibility tests are also expected to challenge market growth to a certain extent. According to research report the global antimicrobial susceptibility testing market size is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.c...
Read more